Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Goodwill (2016 - 2026)

Champions Oncology has reported Goodwill over the past 16 years, most recently at $335000.0 for Q1 2026.

  • Quarterly results put Goodwill at $335000.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Jan 2026 was $335000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $335000.0, changed 0.0%.
  • Goodwill for Q1 2026 was $335000.0 at Champions Oncology, roughly flat from $335000.0 in the prior quarter.
  • Over the last five years, Goodwill for CSBR hit a ceiling of $335000.0 in Q1 2022 and a floor of $335000.0 in Q1 2022.
  • Median Goodwill over the past 5 years was $335000.0 (2022), compared with a mean of $335000.0.
  • Peak annual rise in Goodwill hit 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Champions Oncology's Goodwill stood at $335000.0 in 2022, then changed by 0.0% to $335000.0 in 2023, then changed by 0.0% to $335000.0 in 2024, then changed by 0.0% to $335000.0 in 2025, then changed by 0.0% to $335000.0 in 2026.
  • The last three reported values for Goodwill were $335000.0 (Q1 2026), $335000.0 (Q4 2025), and $335000.0 (Q3 2025) per Business Quant data.